Covered recipient · General Payments record
KAI MITHOEFER
Allopathic & Osteopathic Physicians Orthopaedic Surgery Sports Medicine
General Payments · PY2019–2024
$61,950.27
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,750.00 | 3 |
| Honoraria | $5,225.00 | 4 |
| Food and Beverage | $540.89 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vericel Corporation | $13,602.14 | 9 |
| Miach Orthopaedics, Inc. | $3,750.00 | 1 |
| BIOTISSUE HOLDINGS INC. | $49.89 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $30.73 | 1 |
| Ferring Pharmaceuticals Inc. | $24.44 | 1 |
| Orthofix Medical, Inc. | $23.56 | 1 |
| ConvaTec Inc. | $18.80 | 1 |
| DePuy Synthes Sales Inc. | $16.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $49.89 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148778089 | CMS |
| ConvaTec Inc. | $18.80 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151380467 | CMS |
| DePuy Synthes Sales Inc. | $16.33 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077852952 | CMS |
| Ferring Pharmaceuticals Inc. | $24.44 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137496166 | CMS |
| Miach Orthopaedics, Inc. | $3,750.00 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111023824 | CMS |
| Orthofix Medical, Inc. | $23.56 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127599162 | CMS |
| Vericel Corporation | $1,125.00 | 03/06/2024 | Honoraria | Undisputed | 01/23/2026 | 1128574790 | CMS |
| Vericel Corporation | $139.11 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574792 | CMS |
| Vericel Corporation | $3,000.00 | 05/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1128574794 | CMS |
| Vericel Corporation | $5,000.00 | 08/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1128574796 | CMS |
| Vericel Corporation | $750.00 | 09/19/2024 | Honoraria | Undisputed | 01/23/2026 | 1128574802 | CMS |
| Vericel Corporation | $2,600.00 | 09/24/2024 | Honoraria | Undisputed | 01/23/2026 | 1128574798 | CMS |
| Vericel Corporation | $146.75 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574800 | CMS |
| Vericel Corporation | $750.00 | 10/24/2024 | Honoraria | Undisputed | 01/23/2026 | 1128574804 | CMS |
| Vericel Corporation | $91.28 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574806 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $30.73 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105920589 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.